Professor Daniel Brison, Consultant Embryologist within Research and Innovation at MFT shares his personal motivation for his research journey in this area.
Three commonly prescribed statins are best placed to lower all the ‘bad’ types of cholesterol and prevent cardiovascular disease in people with diabetes, according to a new meta-analysis
Two leading Manchester University NHS Foundation Trust (MFT) researchers have been appointed Senior Investigators by the National Institute for Health Research (NIHR).
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.